Immunicum AB (publ) reported today that the European Patent Office (EPO), has announced that it intends to grant a patent relating to the Company’s cancer immune primer, INTUVAX.
Read the press release here: Press release 151109 – patent EPO
Notice: Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /home/i/immunicu/www/wp-includes/functions.php on line 4805